Clinical Trial Update: TIL-ACT After NMA Chemo with IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating tumor-infiltrating lymphocyte adoptive cell therapy after non-myeloablative chemotherapy with IL-2 and nivolumab rescue in met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• TIL-ACT
• nivolumab (nivolumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Metastatic Melanoma | Phase 1 | Status: COMPLETED